TradingView
RocketTickers
23 apr 2021 19:02
FDA Approves JEMPERLI (dostarlimab-gxly) for dMMR Endometrial Ca
Long
NASDAQ:ANAB
60
AnaptysBio, Inc.
NASDAQ
Descrizione
⋅
23 apr 2021 19:02
ANAB: AnaptysBio, Inc.
2021-04-22 16:12:09
FDA Approves JEMPERLI (dostarlimab-gxly) for dMMR Endometrial Cancer
Beyond Technical Analysis
Altro